about
Before It Gets Started: Regulating Translation at the 5' UTR.RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cellsMicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1Site identification in high-throughput RNA-protein interaction dataA two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.Integrating shotgun proteomics and mRNA expression data to improve protein identificationRNA binding protein HuR regulates the expression of ABCA1.Switch in 3' splice site recognition between exon definition and splicing catalysis is important for sex-lethal autoregulation.Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell lineA compendium of RNA-binding motifs for decoding gene regulation.Leveraging cross-link modification events in CLIP-seq for motif discovery.Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.WTAP is a novel oncogenic protein in acute myeloid leukemiaRiborex: fast and flexible identification of differential translation from Ribo-seq data.Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era.Vascular biology and the sex of flies: regulation of vascular smooth muscle cell proliferation by wilms' tumor 1-associating protein.Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.Musashi1 as a potential therapeutic target and diagnostic marker for lung cancerGenomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.RIP-Chip analysis: RNA-Binding Protein Immunoprecipitation-Microarray (Chip) Profiling.miR-124, -128, and -137 Orchestrate Neural Differentiation by Acting on Overlapping Gene Sets Containing a Highly Connected Transcription Factor Network.Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.RNA processing as an alternative route to attack glioblastoma.A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation.IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.Over-represented sequences located on 3' UTRs are potentially involved in regulatory functionsFrom mechanisms to therapy: RNA processing's impact on human genetics.The 3' end of the story: deciphering combinatorial interactions that control mRNA fate.MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.Molecular characterization of the C-3 DNA puff gene of Rhynchosciara americana.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.Comparing Protein and mRNA Abundances to Protein Expression Regulation.Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cellsIncreased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity.Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma developmentELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated StateThe Diverse Roles of RNA-Binding Proteins in Glioma Development
P50
Q21285057-8489B1D8-D521-4001-A5DA-8865C9F72E54Q24797215-1D34669B-8DC2-48FE-B173-DFDEC2A5C14BQ28115714-9F33F032-5FD0-4798-8208-EA2D1FBA2C24Q30528777-9AB08ED4-219D-4532-9C07-CA169560E310Q33316163-7F10FF0F-8245-47B1-99F0-68027630D078Q33421651-F5004D80-733E-46D1-9D0F-FB9AC9AB6903Q33653613-DD1151D5-CE57-47E8-AF75-0D528FC0EAB8Q33967504-F02ACB93-17E8-4926-8D42-C615ADC1FD77Q34133238-CEDF4FF4-55D4-49A7-AE8C-97FE3A51DE52Q34357005-5C11DC4E-71D1-4832-91E9-7DAE35013C8CQ34883312-8A8815A0-D5B9-4576-83B1-9935EA01D9C8Q34979073-31D5A58A-0B02-4369-96CA-6FD7630FD80AQ35206435-A73A4963-4C73-45C8-8EED-BC43B7547E8CQ36270179-0F74D3DA-A304-4C30-87D8-1716F59222C7Q36657728-29A4F785-E824-45B0-AE70-4F4DB7D7DC62Q36971022-EDC66928-5B45-4C1B-946B-D6AFE6605920Q36991152-70D8582C-9982-4794-BCA7-9C2A01E76B61Q37093544-49824F1E-811E-40F7-8302-2D35CBA3F7D6Q37505070-DD1BA75F-C19C-4390-9098-F22AB8D87E7FQ38338935-CEEE4B1D-7F09-479C-A950-D038AF51C9EDQ38457838-C6B33D8B-FB3C-4699-8220-C8B321F776F7Q38754926-56521DEB-53A9-4A81-A213-C4B6DFAC2FC4Q39368650-C3408600-340E-494D-B5F4-66B43447CFD9Q39848729-DF738CBB-BE1F-494B-9F8B-1036688CF3DDQ42083354-53799379-7005-4F15-8008-811346F80711Q42535836-44BAADD5-34C1-434D-8BB9-224A6EE5F85BQ44013444-53DD716A-F291-433D-A0A8-BDF791ACD458Q46014815-DC1E18E8-819D-4A83-BF78-D5485CC3F6C2Q47616712-6914A25C-7FB8-4A61-B6FE-93D4799C2E5FQ48047383-654FE707-8E6F-4866-853C-A968D94509CBQ52671067-38D317F1-ABE6-44AD-B8AC-9846B26353D7Q55619694-FF36091D-1E54-4897-9A64-1637A797697BQ58550152-3751545B-94CF-45DD-8E48-EB4FB681AAE7Q64921823-DCB51E30-4B04-4C5F-AEC5-BD0DFAFCF032Q90024483-B090F3DE-1025-4A9F-87BF-CDACAD150814Q90780028-416BEC44-2F1E-488D-B790-50F31B05CD29Q92162415-1948C0E5-E420-4A78-BA66-5B3589C714D7
P50
description
researcher
@en
wetenschapper
@nl
name
L O Penalva
@en
L O Penalva
@nl
type
label
L O Penalva
@en
L O Penalva
@nl
prefLabel
L O Penalva
@en
L O Penalva
@nl
P106
P31
P496
0000-0003-4491-6769